Faculty

Institution

Unit

Venue

Kyle Amber

Rush University

Affiliations

Rush Medical College

Department Of Dermatology

News & Events

Rush University

Kyle Amber is a Senior Professor at Rush University specializing in clinical and experimental dermatology, with a focus on autoimmune blistering diseases, particularly bullous pemphigoid, and cutaneous immunology. His recent research investigates immune checkpoint inhibitor-induced bullous pemphigoid, racial disparities in disease outcomes, and inflammatory biomarkers in ocular pemphigoid. He also explores tumor immunology, including B7-H3 and B7-H6/NKp30 axes in melanoma and MD2 targeting in prostate cancer bone metastasis. His work bridges dermatology, oncology, and translational immunology, with publications in the Journal of the American Academy of Dermatology and JID Innovations.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Kyle Amber

Rush University

You can click a keyword to filter the displayed items

dermatology immunology pathology clinical dermatology autoimmune diseases autoimmunity dermatological treatment experimental dermatology bullous pemphigoid venereology veterinary medicine inflammation cutaneous biology public health immune responses dermatopathology melanoma rheumatology psoriasis hematology clinical rheumatology clinical immunology skin pharmacology ocular disease mammalian biology cosmetic dermatology veterinary science rheumatism experimental medicine medicinal research treatment and prevention skin cancer autoantibody production immunologic diseases cancer immunosurveillance cancer biology epidermolysis bullosa acquisita international pemphigus histopathology veterinary parasitology respiratory medicine sport medicine cellular therapy bone research vascular biology autoinflammatory disease cytokines human exposure experimental pathology innate immune system granulocyte inflammatory markers gene expression profiling psychiatric disorders psychiatric diseases atopic dermatitis ocular pathology treatment options treatment development symptomatic treatment veterinary pathology veterinary surgery hormonal receptor unmet medical needs blister fluid levels solar ultraviolet exposure outdoor sport activities international guidelines pemphigoid gestationis mucous membrane pemphigoid non-desmoglein antibodies eosinophil cationic protein human keratinocytes eosinophil-derived neurotoxin pathogenic effects podocyte function

Notable Scholarly Works

Notable Federal Grants

Collaborators

Association of Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid With Underlying Cancer Type: A Lack of Association With Cancer Tissue Col17A1 Mutations and Dysregulation. JID Innovations (2026)

immunologycancer geneticsunderlying cancer typecancer researchmolecular cancerimmune checkpoint inhibitorscancer discoverycancer immunotherapycancer cellscancer biologypathologyimmunotherapy

B7-H6/Nkp30 Axis in Melanoma: Immune Surveillance, Tumor Escape, and Therapeutic Targeting. Preprints.org (2026)

Complement Activation May Drive the Pathogenicity of Anti-α6 and Anti-β4 Integrin Antibodies in Vivo. Biomolecules (2026)

Racial Differences in Comorbidities and Mortality in Us Patients With Bullous Pemphigoid: A Propensity Matched Cohort Study. Journal of the American Academy of Dermatology (2026)

Review of Low‐Dose Naltrexone for Hailey–Hailey Disease Suggests Lack of Benefit in Dose Escalation. International Journal of Dermatology (2026)

medicinepharmacologypharmacotherapyapplied pharmacologyclinical trialsclinical researchlow‐dose naltrexonedose escalation

Serum Inflammatory Biomarkers in Ocular Pemphigoid Closely Resemble That of Dry Eye Disease: A Cross-Sectional Study. The Ocular Surface (2026)

dermatologyophthalmologyautoimmune diseasesocular surface physiologyocular surfacecross-sectional studiesophthalmology retinaserum inflammatory biomarkersdry eye diseaseocular diseaseinflammation

Targeting Md2 in Prostate Cancer Bone Metastasis: Mechanistic Insights and Therapeutic Potential. Oncoscience (2026)

tumor targetingmetastasismolecular cancerurologytherapeutic targetsmechanistic insightsanti-cancer agentsoncologydrug targetingcancer cellscancer biologyprostate cancertherapeutic potentialcell biology

Therapy-Induced Androgen Receptor Signaling as a Candidate Upstream Driver of B7-H3–Linked Immune Exclusion in Melanoma: Mechanisms and Translational Opportunities. Frontiers in Medicine (2026)

immunologydermatologyendocrine-related cancersmelanomamolecular cancercancer immunosurveillancecancer immunotherapycandidate upstream drivertherapy-induced androgen receptorb7-h3–linked immune exclusionimmune responsescancer cellsoncogenesimmunomodulationimmunotherapycell biology

A 15‐Year‐Old Female With Hyperpigmented and Hyperkeratotic Intertriginous Plaques. Pediatric Dermatology (2025)

Antigen-Presenting Cell Phenotype of Skin-Infiltrating Eosinophils in Bullous Pemphigoid Patients. European Journal of Dermatology (2025)

1
2
3
4
5
12
10 / page

Kyle Amber

Rush University

Affiliations

Rush Medical College

Department Of Dermatology

News & Events

Rush University

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Kyle Amber

Rush University

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

immunologycancer geneticsunderlying cancer typecancer researchmolecular cancerimmune checkpoint inhibitorscancer discoverycancer immunotherapycancer cellscancer biologypathologyimmunotherapy

B7-H6/Nkp30 Axis in Melanoma: Immune Surveillance, Tumor Escape, and Therapeutic Targeting. Preprints.org (2026)

Complement Activation May Drive the Pathogenicity of Anti-α6 and Anti-β4 Integrin Antibodies in Vivo. Biomolecules (2026)

Racial Differences in Comorbidities and Mortality in Us Patients With Bullous Pemphigoid: A Propensity Matched Cohort Study. Journal of the American Academy of Dermatology (2026)

Review of Low‐Dose Naltrexone for Hailey–Hailey Disease Suggests Lack of Benefit in Dose Escalation. International Journal of Dermatology (2026)

medicinepharmacologypharmacotherapyapplied pharmacologyclinical trialsclinical researchlow‐dose naltrexonedose escalation

Serum Inflammatory Biomarkers in Ocular Pemphigoid Closely Resemble That of Dry Eye Disease: A Cross-Sectional Study. The Ocular Surface (2026)

dermatologyophthalmologyautoimmune diseasesocular surface physiologyocular surfacecross-sectional studiesophthalmology retinaserum inflammatory biomarkersdry eye diseaseocular diseaseinflammation

Targeting Md2 in Prostate Cancer Bone Metastasis: Mechanistic Insights and Therapeutic Potential. Oncoscience (2026)

Therapy-Induced Androgen Receptor Signaling as a Candidate Upstream Driver of B7-H3–Linked Immune Exclusion in Melanoma: Mechanisms and Translational Opportunities. Frontiers in Medicine (2026)

A 15‐Year‐Old Female With Hyperpigmented and Hyperkeratotic Intertriginous Plaques. Pediatric Dermatology (2025)

Antigen-Presenting Cell Phenotype of Skin-Infiltrating Eosinophils in Bullous Pemphigoid Patients. European Journal of Dermatology (2025)

1
2
3
4
5
12
10 / page